Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
Publication|Articles|August 23, 2023
- August 2023
- Volume 89
- Issue 8
August 2023 Pet Peeves
Advertisement
Too Late
Patients who tell the pharmacist about a discount card after they’ve already paid.
Articles in this issue
about 3 years ago
Fun Facts: August 2023about 3 years ago
Zero in on Professionalism When Strengthening Communication Skillsabout 3 years ago
Interactive Case Studies: August 2023about 3 years ago
Opioid Safety Is a Vital Part of Medication Therapy Managementabout 3 years ago
The Medicine Shoppe Emphasizes Personalized Careabout 3 years ago
Dry Eye Reliefabout 3 years ago
Zydus Pharmaceuticals (USA) Inc. Profileabout 3 years ago
August 2023: Skin Health Watchabout 3 years ago
August Generic Product NewsAdvertisement
Related to this article
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Contraceptive access gaps driven by federal rollbacks, provider shortages, and stalled state legislation could be narrowed by letting trained pharmacists prescribe birth control independently.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
New European Respiratory Society (ERS) update makes sotatercept a strong add-on recommendation, opening a fourth pathway for pharmacists to manage.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Adult Pneumococcal Immunizations: A Practical Guide for Pharmacists
2
How Pharmacists Overcome PCSK9 Inhibitor Access Barriers
3
FDA Approves Rebisufligene Etisparvovec as First Gene Therapy for Children With Sanfilippo Syndrome Type A
4
Beyond Cost Avoidance: Advancing Unit-Level Pharmaceutical Economics in Health Systems
5